Your search returned 2 results.

Results
	1.	Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib. [electronic resource] by Ren, Xiaomei Pan, Xiaofen Zhang, Zhang Wang, Deping Lu, Xiaoyun Li, Yupeng Wen, Donghai Long, Huoyou Luo, Jinfeng Feng, Yubing Zhuang, Xiaoxi Zhang, Fengxiang Liu, Jianqi Leng, Fang Lang, Xingfen Bai, Yang She, Miaoqin Tu, Zhengchao Pan, Jingxuan Ding, Ke Producer: 20130419 In: Journal of medicinal chemistry vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Evaluation of aminohydantoins as a novel class of antimalarial agents. [electronic resource] by Meyers, Marvin J Tortorella, Micky D Xu, Jing Qin, Limei He, Zhengxiang Lang, Xingfen Zeng, Wentian Xu, Wanwan Qin, Li Prinsen, Michael J Sverdrup, Francis M Eickhoff, Christopher S Griggs, David W Oliva, Jonathan Ruminski, Peter G Jacobsen, E Jon Campbell, Mary A Wood, David C Goldberg, Daniel E Liu, Xiaorong Lu, Yongzhi Lu, Xin Tu, Zhengchao Lu, Xiaoyun Ding, Ke Chen, Xiaoping Producer: 20140605 In: ACS medicinal chemistry letters vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search